Presented robust CRB-701 clinical data at ESMO 2025 - 3.6 mg/kg dose generated ORR of 47.6% in HNSCC, 37.5% in cervical cancer and 55.6% in ...
TipRanks on MSN
Corbus Pharmaceuticals Completes $75 Million Public Offering
The most recent analyst rating on (CRBP) stock is a Buy with a $39.00 price target. To see the full list of analyst forecasts on Corbus Pharmaceuticals stock, see the CRBP Stock Forecast page.
Zelenectide pevedotin (BT8009) demonstrated a well-tolerated safety profile and promising antitumor activity in patients with ...
StockStory.org on MSN
The 5 Most Interesting Analyst Questions From Graphic Packaging Holding’s Q3 Earnings Call
Graphic Packaging Holding’s third quarter saw revenue and non-GAAP profit ahead of Wall Street expectations, which ...
Rick Weil and Melanie Yermack serve as transaction leads. Mesirow acted as the exclusive financial advisor on this ...
Detailed price information for The Baldwin Insurance Group Inc (BWIN-Q) from The Globe and Mail including charting and trades.
Adelaide recorded 48 property sales over a million dollars last week, the latest auction and sales results reveal. The number ...
EDITOR'S NOTE: This story has been updated. INDIANAPOLIS — It was another rainy IHSAA state track meet for the Bloomington North boys team this year, but this time, there was a nice ray of sunshine at ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果